Here's the live share price of Anthem Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Anthem Biosciences | 8.94 | 19.34 | 13.75 | 28.92 | 18.33 | 6.88 | 4.08 |
| Sun Pharmaceutical Industries | -1.02 | 0.83 | 3.61 | 13.41 | 20.30 | 19.66 | 20.01 |
| Divi's Laboratories | 1.98 | 23.13 | 27.15 | 31.86 | 42.55 | 32.42 | 11.66 |
| Torrent Pharmaceuticals | -2.81 | -1.20 | 8.18 | 20.51 | 35.29 | 34.82 | 27.50 |
| Zydus Lifesciences | 5.50 | 4.33 | 23.35 | 31.40 | 23.50 | 21.92 | 15.92 |
| Cipla | 0.83 | 2.47 | 12.06 | 8.32 | -2.76 | 5.34 | 9.94 |
| Lupin | -4.12 | -8.80 | 1.44 | 3.14 | 17.05 | 28.37 | 16.75 |
| Dr. Reddy's Laboratories | 3.82 | -2.40 | -5.84 | -5.14 | -1.16 | 1.19 | 4.90 |
| Laurus Labs | 1.33 | 19.41 | 46.86 | 83.60 | 123.75 | 68.59 | 21.49 |
| Mankind Pharma | -1.46 | -3.36 | -1.79 | 16.21 | -0.47 | 9.75 | 11.23 |
| Aurobindo Pharma | 3.67 | 5.96 | 10.51 | 43.28 | 55.97 | 23.91 | 13.89 |
| Biocon | 1.14 | 4.74 | 10.12 | 14.42 | 25.71 | 18.80 | 2.91 |
| Alkem Laboratories | 0.18 | -1.16 | -1.58 | -6.42 | 13.79 | 13.01 | 8.38 |
| Glenmark Pharmaceuticals | 3.20 | -0.50 | -2.56 | 13.62 | 11.82 | 41.89 | 31.71 |
| Abbott India | 0.66 | 2.36 | 0.91 | 4.22 | -15.06 | 5.70 | 8.89 |
| Gland Pharma | 13.31 | 18.86 | 52.30 | 56.71 | 51.01 | 21.02 | -6.77 |
| Ipca Laboratories | 3.99 | -4.10 | 14.09 | 22.05 | 30.81 | 24.50 | 7.69 |
| GlaxoSmithKline Pharmaceuticals | -1.75 | 7.60 | 6.78 | -3.70 | -3.24 | 21.74 | 9.92 |
| Ajanta Pharma | -0.55 | 2.32 | 14.29 | 20.55 | 32.30 | 26.69 | 18.48 |
| J B Chemicals & Pharmaceuticals | -3.00 | 9.24 | 21.04 | 27.99 | 43.16 | 24.30 | 21.27 |
Source: Dion Global
Over the last one year, Anthem Biosciences has gained 18.33% compared to peers like Sun Pharmaceutical Industries (20.30%), Divi's Laboratories (42.55%), Torrent Pharmaceuticals (35.29%). From a 5 year perspective, Anthem Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (20.01%) and Divi's Laboratories (11.66%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 821.81 | 825.9 |
| 10 | 802.62 | 813.36 |
| 20 | 785.28 | 798.41 |
| 50 | 774.77 | 779.1 |
| 100 | 749.13 | 758.09 |
| 200 | 707.38 | 742.19 |
Source: Dion Global
In the latest quarter, Anthem Biosciences saw a drop in promoter holding to 71.42%, while DII stake increased to 13.48%, FII holding rose to 2.57%, and public shareholding moved up to 12.52% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 83,27,643 | 0.6 | 641.69 | |
| 47,86,459 | 4.53 | 368.82 | |
| 43,18,200 | 1.38 | 332.74 | |
| 33,10,278 | 0.76 | 255.07 | |
| 25,00,485 | 0.6 | 192.67 | |
| 24,50,000 | 0.71 | 188.78 | |
| 22,99,000 | 2.82 | 177.15 | |
| 18,40,000 | 2.84 | 141.78 | |
| 15,63,383 | 0.36 | 120.47 | |
| 13,35,040 | 3.81 | 102.87 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jul 27, 2026, 04:23 PM IST IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Jul 24, 2026, 09:37 PM IST IST | Anthem Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Jul 23, 2026, 05:24 AM IST IST | Anthem Biosciences - Announcement Under |
| Jul 22, 2026, 11:38 PM IST IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Jul 22, 2026, 12:55 AM IST IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) |
Source: Dion Global
Anthem Biosciences Ltd. is a Public Limited Listed company incorporated on 13/06/2006 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is U24233KA2006PLC039703 and registration number is 039703. Currently Company is involved in the business activities of Scientific research and development. Company's Total Operating Revenue is Rs. 2089.31 Cr. and Equity Capital is Rs. 112.34 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Anthem Biosciences is ₹891.80 as on Aug 11, 2026.
The Anthem Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Anthem Biosciences is ₹50,225.74 Cr as on Aug 11, 2026.
Today’s highest and lowest price of Anthem Biosciences are ₹899.35 and ₹853.35.
The 52-week high/low is the highest and lowest price at which Anthem Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Anthem Biosciences is ₹873.25 and 52-week low of Anthem Biosciences is ₹579.45 as on Aug 11, 2026.
The Anthem Biosciences has shown returns of 4.51% over the past day, 19.34% for the past month, 13.75% over 3 months, 18.33% over 1 year, 6.88% across 3 years, and 4.08% over 5 years.
P/E ratio of and PB ratio of Anthem Biosciences are 87.21 and 16.51 on Aug 11, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global